Government to support new drug discovery for schizophrenia.

The MOHW plans to develope AAD-200, a new candidate compount for the treatment of Alzheimer, schizophrenia and Parkinsonian disorders, which was discovered as a frontier project of the brain research in Korea.

The MOHW is going to spend about 20 billion won for 3 years (60% by the government and 40% by the private investment) for its preclinical tests (animal toxicity and pharmacology test) ...